Combining ferroptosis induction with MDSC blockade renders primary tumours and metastases in liver sensitive to immune checkpoint blockade.
Claire ConcheFabian FinkelmeierMarina PešićAdele M NicolasTim W BöttgerKilian B KennelDominic DenkFatih CeteciKathleen MohsEsther EngelÖzge CanliYasamin DabiriKai-Hendrik PeifferStefan ZeuzemGabriela SalinasThomas LongerichHuan YangFlorian R GretenPublished in: Gut (2023)
Our data highlight a context-specific ferroptosis-induced immune response that could be therapeutically exploited for the treatment of primary liver tumours and liver metastases.